FASEB SRC on G Protein-Coupled Receptor Kinases and Arrestins: From Structure to Disease

FASEB SRC 关于 G 蛋白偶联受体激酶和抑制蛋白:从结构到疾病

基本信息

  • 批准号:
    9330648
  • 负责人:
  • 金额:
    $ 1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-15 至 2018-06-14
  • 项目状态:
    已结题

项目摘要

Summary G protein-coupled receptors (GPCRs) and their downstream signaling pathways are important for the regulation of many essential cellular processes and are targets of some of the most commonly prescribed drugs, such as those used to treat pain, heart failure, and high blood pressure (e.g. morphine,  blockers, and angiotensin inhibitors, respectively). GPCR kinases (GRKs) and arrestins work together to regulate GPCR signaling by reducing the ability of receptors to couple with G proteins and by targeting active GPCRs for endocytosis. Although these desensitization mechanisms are important for returning cells to their physiological resting states, GRKs and arrestins are also thought to play prominent roles in addiction and cardiovascular disease, at least in part by instigating other, non-canonical signaling cascades. This proposal seeks funding for a forum that would bring together world-leading researchers who study different aspects of GRK and arrestin biology and their roles in disease called "G Protein-Coupled Receptor Kinases and Arrestins: From Structure to Disease". Two major highlights of the meeting will be keynote lectures by 2012 Nobel laureates who are experts in GPCR, GRK, and arrestin structure, function, and cell biology. The meeting is expected to not only stimulate the generation of new hypotheses, collaborations, and methodologies that can be used to study and combat drug abuse and cardiovascular disease, but also provide career advancement and speaking opportunities for junior investigators and underrepresented groups of scientists.
总结 G蛋白偶联受体(GPCR)及其下游信号通路对于免疫应答是重要的。 调节许多基本的细胞过程,是一些最常用的处方的目标 药物,如用于治疗疼痛、心力衰竭和高血压的药物(如吗啡、多巴胺受体阻滞剂和 血管紧张素抑制剂)。GPCR激酶(GRKs)和抑制蛋白共同作用调节GPCR 通过降低受体与G蛋白偶联的能力和通过靶向活性GPCR来抑制G蛋白的表达, 内吞作用尽管这些脱敏机制对于使细胞恢复其生理状态很重要, 静息状态、GRK和抑制蛋白也被认为在成瘾和心血管疾病中起重要作用。 疾病,至少部分通过煽动其他非经典信号级联。该提案寻求资金, 该论坛将汇集世界领先的研究人员,他们研究GRK和arrestin的不同方面 G蛋白偶联受体激酶和抑制蛋白:从结构到功能 疾病”。会议的两大亮点将是2012年诺贝尔奖获得者的主题演讲, GPCR、GRK和arrestin结构、功能和细胞生物学专家。预计会议不仅将 鼓励产生新的假设,合作和方法,可用于研究和 打击药物滥用和心血管疾病,但也提供职业发展和发言 为初级研究人员和代表性不足的科学家群体提供机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John Tesmer其他文献

John Tesmer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John Tesmer', 18)}}的其他基金

New X-ray Diffractometer and Detector for Purdue Macromolecular Crystallography
用于普渡大学高分子晶体学的新型 X 射线衍射仪和探测器
  • 批准号:
    10431439
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
GPCR - Linked RhoGEFs in Tumor Growth and Metastasis
GPCR - 连接 RhoGEF 在肿瘤生长和转移中的作用
  • 批准号:
    10338123
  • 财政年份:
    2018
  • 资助金额:
    $ 1万
  • 项目类别:
Structure and Function of the LPLA2/LCAT Acyltransferase Family
LPLA2/LCAT 酰基转移酶家族的结构和功能
  • 批准号:
    9174909
  • 财政年份:
    2014
  • 资助金额:
    $ 1万
  • 项目类别:
Structure and Function of the LPLA2/LCAT Acyltransferase Family
LPLA2/LCAT 酰基转移酶家族的结构和功能
  • 批准号:
    8817382
  • 财政年份:
    2014
  • 资助金额:
    $ 1万
  • 项目类别:
RNA Aptamer-Based Screen for Selective Inhibitors of GRK2
基于 RNA 适体的 GRK2 选择性抑制剂筛选
  • 批准号:
    7929294
  • 财政年份:
    2010
  • 资助金额:
    $ 1万
  • 项目类别:
RNA Aptamer-Based Screen for Selective Inhibitors of GRK2
基于 RNA 适体的 GRK2 选择性抑制剂筛选
  • 批准号:
    8063896
  • 财政年份:
    2010
  • 资助金额:
    $ 1万
  • 项目类别:
Molecular basis for the regulation of G protein-coupled receptor kinases
G蛋白偶联受体激酶调节的分子基础
  • 批准号:
    8281593
  • 财政年份:
    2009
  • 资助金额:
    $ 1万
  • 项目类别:
Molecular basis for the regulation of G protein-coupled receptor kinases
G蛋白偶联受体激酶调节的分子基础
  • 批准号:
    7906035
  • 财政年份:
    2009
  • 资助金额:
    $ 1万
  • 项目类别:
Phosphorylation and G Protein Signaling Networks Gordon Conferences
磷酸化和 G 蛋白信号转导网络 Gordon Conferences
  • 批准号:
    8076873
  • 财政年份:
    2009
  • 资助金额:
    $ 1万
  • 项目类别:
Molecular basis for the regulation of G protein-coupled receptor kinases
G蛋白偶联受体激酶调节的分子基础
  • 批准号:
    7736619
  • 财政年份:
    2009
  • 资助金额:
    $ 1万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了